BNRA Stock Chart & Stats
€11.50
€0.10(0.88%)
At close: 4:00 PM EDT
€11.50
€0.10(0.88%)
Day’s Range― - ―
52-Week Range€8.60 - €12.70
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€8.79B
Enterprise Value€12.34K
Total Cash (Recent Filing)€508.79M
Total Debt (Recent Filing)€3.61B
Price to Earnings (P/E)24.5
Beta0.82
Next Earnings
Nov 11, 2026EPS Estimate
0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.50
Shares Outstanding721,926,800
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.53
Price to Book (P/B)1.65
Price to Sales (P/S)0.49
P/FCF Ratio11.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.81
Revenue Forecast (FY)€15.37B
Bulls Say, Bears Say
Bulls Say
Diversified Chemical Distribution PlatformThe broad product portfolio, global distribution infrastructure and value-added services create customer utility beyond simple resale. This supports recurring relationships, supplier access and resilience across industrial and specialty end markets.
Improving Sales And Operating ConversionDouble-digit sales growth combined with better gross-profit performance and EBITDA conversion indicates improving commercial execution and operating leverage. If sustained, these gains can strengthen earnings quality despite mixed demand across segments.
Structural Cost Savings ExecutionProgress on productivity initiatives and workforce restructuring can lower the company’s structural cost base and improve competitiveness. The sizable multiyear savings targets provide a potential cushion if volumes or market pricing weaken.
Bears Say
Compressed ProfitabilityLower profitability and returns show that Brenntag’s earnings power remains below prior peaks. Thin net margins leave less room to absorb pricing pressure, weaker volumes, higher operating costs or unfavorable product mix changes.
Weaker Cash Flexibility And Higher LeveragePositive cash generation remains supportive, but declining free cash flow and weaker debt coverage reduce financial flexibility. Rising leverage further increases sensitivity to softer demand, working-capital needs and prolonged margin pressure.
Flat Volumes And Competitive PressureLimited volume growth and uneven specialty demand constrain organic expansion, while renewed regional competition may pressure prices and margins. These risks could persist beyond one quarter if customer demand and industry supply remain unsettled.
Brenntag AG News
BNRA FAQ
What was Brenntag AG’s price range in the past 12 months?
Brenntag AG lowest stock price was €8.60 and its highest was €12.70 in the past 12 months.
What is Brenntag AG’s market cap?
Brenntag AG’s market cap is €8.79B.
When is Brenntag AG’s upcoming earnings report date?
Brenntag AG’s upcoming earnings report date is Nov 11, 2026 which is in 83 days.
How were Brenntag AG’s earnings last quarter?
Brenntag AG released its earnings results on Aug 12, 2026. The company reported €0.243 earnings per share for the quarter, missing the consensus estimate of €0.338 by -€0.095.
Is Brenntag AG overvalued?
According to Wall Street analysts Brenntag AG’s price is currently Overvalued.
Does Brenntag AG pay dividends?
Brenntag AG does not currently pay dividends.
What is Brenntag AG’s EPS estimate?
Brenntag AG’s EPS estimate is 0.22.
How many shares outstanding does Brenntag AG have?
Brenntag AG has 721,926,800 shares outstanding.
What happened to Brenntag AG’s price movement after its last earnings report?
Brenntag AG reported an EPS of €0.243 in its last earnings report, missing expectations of €0.338. Following the earnings report the stock price went down -0.813%.
Which hedge fund is a major shareholder of Brenntag AG?
Currently, no hedge funds are holding shares in DE:BNRA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Brenntag AG Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-1.57%
12-Months-Change
Fundamentals
Return on Equity
3.18%
Trailing 12-Months
Asset Growth
5.34%
Trailing 12-Months
Company Description
Brenntag AG
Brenntag SE functions as a major global distributor, procuring and supplying a comprehensive range of industrial and specialty chemicals, as well as essential ingredients. Its extensive operations span across Europe, the Middle East, Africa, the Americas (North and Latin), and the Asia Pacific region. The company organizes its business through two primary divisions: Brenntag Essentials and Brenntag Specialties. Beyond simply distributing products, Brenntag delivers a suite of value-added services to its clients. These services encompass efficient logistics like just-in-time delivery and managing drum returns, as well as product customization through mixing, blending, and repackaging. Additionally, they provide crucial support with inventory management and offer specialized technical and laboratory services tailored for their specialty chemical offerings. Brenntag serves a diverse array of end-market industries, including vital sectors such as nutrition, pharmaceuticals, personal care, water treatment, and lubricants. Its clientele also extends to the home, industrial, and institutional markets, alongside industries like coatings, construction, polymers, and rubber. Founded in 1874, Brenntag SE is headquartered in Essen, Germany.
BNRA Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a net-positive operational and financial picture: double-digit sales growth, margin expansion, improved EBITDA conversion and clear progress on structural cost savings and commercial initiatives. These positives were tempered by a large but described-as-temporary working capital build driven by price effects, elevated personnel costs due to bonus provisions (~EUR 40m), flat volumes in some FY-critical businesses (notably Nutrition), and continued external uncertainty (geopolitics, competitor dynamics). Management expects the working capital peak to unwind into Q3 and reiterated delivery of cost-savings targets, while taking a conservative stance on H2 gross profit assumptions.View all DE:BNRA earnings summaries